Jaguar Health, Inc. (JAGX) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Jaguar Health, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.212 Good afternoon. Before I turn the call over to management, I'd like to remind you that 00:00:04.212 -- 00:00:09.333 management may make forward-looking statements relating to matters such as continued 00:00:09.333 -- 00:00:14.775 growth prospects for the company, uncertainties regarding market acceptance of products, 00:00:14.775 -- 00:00:19.676 the impact of competitive products and pricing, industry trends, and product initiatives, 00:00:19.676 -- 00:00:24.357 including products in the development stage which may not achieve scientific objectives 00:00:24.357 -- 00:00:28.078 or meet stringent regulatory requirements. 00:00:28.370 -- 00:00:32.274 Forward-looking statements are subject to risks and uncertainties that could cause actual 00:00:32.274 -- 00:00:37.038 results to differ materially from those contemplated in such forward-looking statements. 00:00:37.038 -- 00:00:40.802 These statements are based on currently available information and management's current 00:00:40.802 -- 00:00:44.587 assumptions, expectations, and projections about future events. 00:00:44.587 -- 00:00:48.969 While management believes its assumptions, expectations, and projections are reasonable 00:00:48.969 -- 00:00:53.550 in view of currently available information, you are cautioned not to place under reliance 00:00:53.550 -- 00:00:57.612 on these forward-looking statements. The company's action results may differ materially 00:00:57.612 -- 00:01:02.134 from those discussed during this webcast for a variety of reasons, including those described 00:01:02.134 -- 00:01:06.555 in the forward-looking statements and risk factors section of the company's Form 10-K 00:01:06.555 -- 00:01:08.806 for the year 2025. 00:01:08.806 -- 00:01:14.520 which was filed with ...